BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW, Lancon C, Auquier P, Baumstarck K, Llorca PM, Yon DK, Boyer L. Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis. JAMA Psychiatry 2021. [PMID: 34313711 DOI: 10.1001/jamapsychiatry.2021.2274] [Cited by in Crossref: 54] [Cited by in F6Publishing: 64] [Article Influence: 54.0] [Reference Citation Analysis]
Number Citing Articles
1 Pretorius TB, Padmanabhanunni A, Isaacs SA. The dynamics of Appraisal II: a meta-analysis of the relationship between fortitude and the indices of psychological well-being. South African Journal of Psychology 2022. [DOI: 10.1177/00812463221140245] [Reference Citation Analysis]
2 Ford BN, Savitz J. Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity. Immun Ageing 2022;19:32. [DOI: 10.1186/s12979-022-00288-7] [Reference Citation Analysis]
3 Mofazzal Jahromi MA, Sefidfard M, Taghipour A, Roustazadeh A, Matin S, Mir H, Badri M, Bahrami F, Abdoli A. Latent infections, coronavirus disease 2019 and psychiatric disorders: The friend of my enemy. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.141] [Reference Citation Analysis]
4 Padmanabhanunni A, Pretorius TB. From fear and vulnerability to fortitude: sustaining psychological well-being in the face of the COVID-19 pandemic. South African Journal of Psychology 2022. [DOI: 10.1177/00812463221137876] [Reference Citation Analysis]
5 Nishimi K, Neylan TC, Bertenthal D, Dolsen EA, Seal KH, O’donovan A. Post-traumatic stress disorder and risk for hospitalization and death following COVID-19 infection. Transl Psychiatry 2022;12:482. [DOI: 10.1038/s41398-022-02156-w] [Reference Citation Analysis]
6 Gholami F, Farshid S, Soleimani P, Valizadeh R. Role of Vitamin D in Patients with Schizophrenia Suffering from COVID-19. Vitamin D Deficiency - New Insights [Working Title] 2022. [DOI: 10.5772/intechopen.108352] [Reference Citation Analysis]
7 Ranger TA, Clift AK, Patone M, Coupland CAC, Hatch R, Thomas K, Watkinson P, Hippisley-cox J. Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections. JAMA Psychiatry 2022. [DOI: 10.1001/jamapsychiatry.2022.3614] [Reference Citation Analysis]
8 Forster SE, Gancz NN, Gaither ML, Haas GL, Starver KD, Steinhauer SR. Barriers to Long-acting Injectable Antipsychotic Adherence During the COVID-19 Pandemic: Observations From One Site. Journal of Psychiatric Practice 2022;28:497-504. [DOI: 10.1097/pra.0000000000000673] [Reference Citation Analysis]
9 Friedman C. COVID-19 infection differences among people with disabilities. Dialogues in Health 2022. [DOI: 10.1016/j.dialog.2022.100083] [Reference Citation Analysis]
10 Descamps A, Frenkiel J, Zarca K, Laidi C, Godin O, Launay O, Leboyer M, Durand-zaleski I. Association between mental disorders and COVID-19 outcomes among inpatients in France: A retrospective nationwide population-based study. Journal of Psychiatric Research 2022;155:194-201. [DOI: 10.1016/j.jpsychires.2022.08.019] [Reference Citation Analysis]
11 Berger M. Covid-19 and long covid highlight the need to tackle behavioural health challenges. BMJ 2022;379:o2502. [PMID: 36261140 DOI: 10.1136/bmj.o2502] [Reference Citation Analysis]
12 Boyer L, Fond G, Pauly V, Orléans V, Auquier P, Solmi M, Correll CU, Yon DK, Llorca PM, Baumstarck-Barrau K, Duclos A. Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study. Mol Psychiatry 2022. [PMID: 36207583 DOI: 10.1038/s41380-022-01803-4] [Reference Citation Analysis]
13 Cai H, Bai W, Du X, Zhang L, Zhang L, Li YC, Liu HZ, Tang YL, Jackson T, Cheung T, An FR, Xiang YT. COVID-19 vaccine acceptance and perceived stigma in patients with depression: a network perspective. Transl Psychiatry 2022;12:429. [PMID: 36195590 DOI: 10.1038/s41398-022-02170-y] [Reference Citation Analysis]
14 Xu H, Li S, Mehta HB, Hommel EL, Goodwin JS. Excess deaths from COVID-19 among Medicare beneficiaries with psychiatric diagnoses: community versus nursing home. J Am Geriatr Soc 2022. [PMID: 36137264 DOI: 10.1111/jgs.18062] [Reference Citation Analysis]
15 Conway KP, Bhardwaj K, Michel E, Paksarian D, Nikolaidis A, Kang M, Merikangas KR, Milham MP. Association between COVID-19 Risk-Mitigation Behaviors and Specific Mental Disorders in Youth.. [DOI: 10.21203/rs.3.rs-2026969/v1] [Reference Citation Analysis]
16 Morar T, Robertson L. Smoking cessation among people with mental illness: A South African perspective. S Afr Fam Pract 2022;64. [DOI: 10.4102/safp.v64i1.5489] [Reference Citation Analysis]
17 Hassan L, Sawyer C, Peek N, Lovell K, Carvalho AF, Solmi M, Tilston G, Sperrin M, Firth J. Heightened COVID-19 Mortality in People With Severe Mental Illness Persists After Vaccination: A Cohort Study of Greater Manchester Residents. Schizophr Bull 2022:sbac118. [PMID: 36029257 DOI: 10.1093/schbul/sbac118] [Reference Citation Analysis]
18 Chen A, Beste LA, Strack K, Geyer J, Wheat C, Nelson K, Reddy A. COVID-19 Vaccinations Among US Veterans with Mental Illness: a Retrospective Cohort Study. J Gen Intern Med 2022. [PMID: 35970960 DOI: 10.1007/s11606-022-07763-3] [Reference Citation Analysis]
19 Akinyemi AA. Historical trauma compounds experiences of racial injustice. Nat Hum Behav 2022. [PMID: 35970903 DOI: 10.1038/s41562-022-01435-2] [Reference Citation Analysis]
20 Fond G, Yon DK, Boyer L. One-year results from the vaccination campaign against COVID-19 infection in 47 million individuals with severe mental disorders and other chronic diseases. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35969276 DOI: 10.1007/s00406-022-01467-9] [Reference Citation Analysis]
21 Kendzerska T, Zhu DT, Pugliese M, Manuel D, Sadatsafavi M, Povitz M, Stukel TA, To T, Aaron SD, Mulpuru S, Chin M, Kendall CE, Thavorn K, Robillard R, Gershon AS. Trends in all-cause mortality and inpatient and outpatient visits for ambulatory care sensitive conditions during the first year of the COVID-19 pandemic: A population-based study. J Hosp Med 2022. [PMID: 35929531 DOI: 10.1002/jhm.12920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bazrafshan M, Sadeghi R, Khajoei R, Mohseni M, Moqaddasi Amiri M, Masmouei B, Soufi O, Masoudi MR. Hospital Mortality in COVID-19 Patients with Chronic Diseases: A Retrospective Cohort Study in Sirjan, Iran, in 2021. Jundishapur J Chronic Dis Care 2022;11. [DOI: 10.5812/jjcdc-124027] [Reference Citation Analysis]
23 Meier K, van Hoeken D, Hoek HW. Review of the unprecedented impact of the COVID-19 pandemic on the occurrence of eating disorders. Curr Opin Psychiatry 2022. [PMID: 35903873 DOI: 10.1097/YCO.0000000000000815] [Reference Citation Analysis]
24 Rozental A, Sörman K, Ojala O, Jangard S, El Alaoui S, Månsson KNT, Shahnavaz S, Lundin J, Forsström D, Hedman-lagerlöf M, Lundgren T, Jayaram-lindström N. Mental health in individuals with self-reported psychiatric symptoms during the COVID-19 pandemic: Baseline data from a swedish longitudinal cohort study. Front Psychiatry 2022;13:933858. [DOI: 10.3389/fpsyt.2022.933858] [Reference Citation Analysis]
25 Hu Y, Rehawi G, Moyon L, Gerstner N, Ogris C, Knauer-arloth J, Bittner F, Marsico A, Mueller NS. Network Embedding Across Multiple Tissues and Data Modalities Elucidates the Context of Host Factors Important for COVID-19 Infection. Front Genet 2022;13:909714. [DOI: 10.3389/fgene.2022.909714] [Reference Citation Analysis]
26 Koyama AK, Koumans EH, Sircar K, Lavery AM, Ko JY, Hsu J, Anderson KN, Siegel DA. Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States. Emerg Infect Dis 2022;28:1533-6. [PMID: 35731203 DOI: 10.3201/eid2807.212208] [Reference Citation Analysis]
27 Qiao S, Zhang J, Chen S, Olatosi B, Hardeman S, Narasimhan M, Bruner L, Diedhiou A, Scott C, Mansaray A, Weissman S, Li X. How Different Pre-existing Mental Disorders and Their Co-occurrence Affects COVID-19 Clinical Outcomes? A Real-World Data Study in the Southern United States. Front Public Health 2022;10:831189. [DOI: 10.3389/fpubh.2022.831189] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Beckstein A, Chollier M, Kaur S, Ghimire AR. Mental Wellbeing and Boosting Resilience to Mitigate the Adverse Consequences of the COVID-19 Pandemic: A Critical Narrative Review. SAGE Open 2022;12:215824402211004. [DOI: 10.1177/21582440221100455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Nemani K, Williams SZ, Olfson M, Leckman-Westin E, Finnerty M, Kammer J, Smith TE, Silverman DJ, Lindenmayer JP, Capichioni G, Clelland J, Goff DC. Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System. JAMA Netw Open 2022;5:e2210743. [PMID: 35522282 DOI: 10.1001/jamanetworkopen.2022.10743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
30 Moore HE, Hill B, Tanser F, Siriwardena AN, Gussy M, Cutts M, Spaight R. Characterizing Unusual Spatial Clusters of Male Mental Health Emergencies Occurring During the First National COVID-19 "Lockdown" in the East Midlands Region, UK: A Geospatial Analysis of Ambulance 999 Data. Am J Mens Health 2022;16:15579883221097539. [PMID: 35579400 DOI: 10.1177/15579883221097539] [Reference Citation Analysis]
31 Danışman M, İspir GZ, Oğur B. Delirium Tremens and Central Pontine Myelinolysis in a Patient with Alcohol Use Disorder and Pneumonia: a Case Report and a Narrative Review. Fortschr Neurol Psychiatr 2022. [PMID: 35483887 DOI: 10.1055/a-1778-3727] [Reference Citation Analysis]
32 Goldberger N, Bergman-Levy T, Haklai Z, Yoffe R, Davidson M, Susser E, Levi L, Elhasid T, Weiser M. COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study. Mol Psychiatry 2022. [PMID: 35459901 DOI: 10.1038/s41380-022-01562-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Luo S, Liang Y, Wong THT, Schooling CM, Au Yeung SL. Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies. Int J Epidemiol 2022:dyac076. [PMID: 35445260 DOI: 10.1093/ije/dyac076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
34 Kim SY, Lee N, Yoo DM, Kim JH, Kwon MJ, Kim J, Bang WJ, Choi HG. Changes in the Mean of Medical Visits Due to Psychiatric Disease in Korean Children and Adolescents before and during the COVID-19 Pandemic. Life 2022;12:600. [DOI: 10.3390/life12040600] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Nishimi K, Neylan TC, Bertenthal D, Seal KH, O'Donovan A. Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults. JAMA Netw Open 2022;5:e227287. [PMID: 35420660 DOI: 10.1001/jamanetworkopen.2022.7287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Tzur Bitan D, Kridin K, Givon-Lavi N, Krieger I, Kaliner E, Cohen AD, Weinstein O. COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel. JAMA Psychiatry 2022. [PMID: 35353114 DOI: 10.1001/jamapsychiatry.2022.0382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Meinlschmidt G, Guemghar S, Roemmel N, Battegay E, Hunziker S, Schaefert R. Depressive symptoms, but not anxiety, predict subsequent diagnosis of Coronavirus disease 19: a national cohort study. Epidemiol Psychiatr Sci 2022;31:e16. [PMID: 35331365 DOI: 10.1017/S2045796021000676] [Reference Citation Analysis]
38 Veerman SRT, Moscou T, Bogers JPAM, Cohen D, Schulte PFJ. Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study. Acta Psychiatr Scand 2022. [PMID: 35322409 DOI: 10.1111/acps.13428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Conway KP, Bhardwaj K, Michel E, Paksarian D, Nikolaidis A, Kang M, Merikangas KR, Milham MP. Association between COVID-19 Risk-Mitigation Behaviors and Specific Mental Disorders in Youth.. [DOI: 10.1101/2022.03.03.22271787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Sörberg Wallin A, Ohlis A, Dalman C, Ahlen J. Risk of severe COVID-19 infection in individuals with severe mental disorders, substance use disorders, and common mental disorders. General Hospital Psychiatry 2022;75:75-82. [DOI: 10.1016/j.genhosppsych.2022.02.004] [Reference Citation Analysis]
41 Hasin DS, Fink DS, Olfson M, Saxon AJ, Malte C, Keyes KM, Maynard CC, Gradus JL, Cerdá M, Keyhani S, Martins SS, Livne O, Mannes Z, Sherman SE, Wall MM. Substance Use Disorders and COVID-19: an analysis of nation-wide Veterans Health Administration electronic health records. Drug and Alcohol Dependence 2022. [DOI: 10.1016/j.drugalcdep.2022.109383] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Weich S. Mental health after covid-19. BMJ 2022;376:o326. [PMID: 35172977 DOI: 10.1136/bmj.o326] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
43 Shoib S, Bharati‐sinha V, Javed S, Gürcan A, Gürcan G, Das S, Chandradasa M, Saeed F. The disquietude of clozapine continuation during the COVID‐19 pandemic. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Xia J, Chen S, Li Y, Li H, Gan M, Wu J, Prohaska CC, Bai Y, Gao L, Gu L, Zhang D. Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis. Front Immunol 2022;13:798538. [DOI: 10.3389/fimmu.2022.798538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Pardamean E, Roan W, Iskandar KTA, Prayangga R, Hariyanto TI. Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression. General Hospital Psychiatry 2022. [DOI: 10.1016/j.genhosppsych.2022.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 De Hert M, Mazereel V, Stroobants M, De Picker L, Van Assche K, Detraux J. COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review. Front Psychiatry 2021;12:798554. [PMID: 35095612 DOI: 10.3389/fpsyt.2021.798554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
47 Pashaei Y. Fluoxetine and Molnupiravir: A Synergistic Combination for COVID-19 Treatment? Hosp Pharm. [DOI: 10.1177/00185787211073465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Correll CU, Chepke C, Gionfriddo P, Parks J, Foxworth P, Basu A, Brister TS, Brown D, Clarke C, Hassoun Y. The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach. BMC Psychiatry 2022;22:32. [PMID: 35012512 DOI: 10.1186/s12888-022-03685-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
49 Mazereel V, Vanbrabant T, Desplenter F, Detraux J, De Picker L, Thys E, Popelier K, De Hert M. COVID-19 Vaccination Rates in a Cohort Study of Patients With Mental Illness in Residential and Community Care. Front Psychiatry 2021;12:805528. [PMID: 34975599 DOI: 10.3389/fpsyt.2021.805528] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
50 Brewer-smyth K. COVID-19 Trauma: The New Complex Adverse Childhood Experience. Adverse Childhood Experiences 2022. [DOI: 10.1007/978-3-031-08801-8_7] [Reference Citation Analysis]
51 Powell SK, Saali A, Serafini RA, O’shea CP, Frere JJ, Katz CL. Psychological Impacts of the COVID-19 Pandemic. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_10] [Reference Citation Analysis]
52 Vai B, Mazza MG, Marisa CD, Beezhold J, Kärkkäinen H, Saunders J, Samochowiec J, Benedetti F, Leboyer M, Fusar-poli P, De Picker L. Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health. Eur Psychiatr 2022;65:e47. [DOI: 10.1192/j.eurpsy.2022.2307] [Reference Citation Analysis]
53 Decio V, Pirard P, Pignon B, Bouaziz O, Perduca V, Chin F, Le Strat Y, Messika J, Kovess-masfety V, Corruble E, Regnault N, Tebeka S. Hospitalization for COVID-19 is associated with a higher risk of subsequent hospitalization for psychiatric disorders: A French nationwide longitudinal study comparing hospitalizations for COVID-19 and for other reasons. Eur Psychiatr 2022;65:e70. [DOI: 10.1192/j.eurpsy.2022.2331] [Reference Citation Analysis]
54 Bufka LF, Marzalik JS. The psychological impact of the COVID-19 pandemic. Reference Module in Neuroscience and Biobehavioral Psychology 2022. [DOI: 10.1016/b978-0-323-91497-0.00178-8] [Reference Citation Analysis]
55 Gonçalves BMM, Franco RPV, Rodrigues AS. Maternal mortality associated with COVID-19 in Brazil in 2020 and 2021: Comparison with non-pregnant women and men. PLoS One 2021;16:e0261492. [PMID: 34932589 DOI: 10.1371/journal.pone.0261492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
56 Hill SY, Holmes BJ, Locke-wellman J. Factors influencing COVID-19 Infection in older individuals: History of Alcohol Use Disorder, Major Depressive illness, genetic variation and current use of alcohol.. [DOI: 10.1101/2021.12.06.21267386] [Reference Citation Analysis]
57 Ismail H, Marshall VD, Patel M, Tariq M, Mohammad RA. The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases. J Am Pharm Assoc (2003) 2021:S1544-3191(21)00474-X. [PMID: 34844885 DOI: 10.1016/j.japh.2021.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
58 Fatollahi JJ, Bentley S, Doran N, Brody AL. Changes in Tobacco Use Patterns among Veterans in San Diego during the Recent Peak of the COVID-19 Pandemic. Int J Environ Res Public Health 2021;18:11923. [PMID: 34831686 DOI: 10.3390/ijerph182211923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Nguyen NT, Nguyen HQ, O'Neill C. COVID-19 Era Recessional Mortality Continues the Impact of Prepandemic Recessions on Mortality. Am J Public Health 2021;111:1944-6. [PMID: 34709857 DOI: 10.2105/AJPH.2021.306531] [Reference Citation Analysis]
60 Qiao S, Zhang J, Chen S, Olatosi B, Hardeman S, Narasimhan M, Bruner L, Diedhiou A, Scott C, Mansaray A, Weissman S, Li X. How different pre-existing mental disorders and their co-occurrence affects clinical outcomes of COVID-19? A study based on real-world data in the Southern United States.. [DOI: 10.1101/2021.10.21.21265340] [Reference Citation Analysis]
61 Greener M. Latest clinical research. Independent Nurse 2021;2021:10-11. [DOI: 10.12968/indn.2021.9.10] [Reference Citation Analysis]
62 Couser GP, Taylor-Desir M, Lewis S, Griesbach TJ. Further Adaptations and Reflections by an Assertive Community Treatment Team to Serve Clients with Severe Mental Illness During COVID-19. Community Ment Health J 2021;57:1217-26. [PMID: 34146189 DOI: 10.1007/s10597-021-00860-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]